Logo image of MDLZ

MONDELEZ INTERNATIONAL INC-A (MDLZ) Stock Fundamental Analysis

NASDAQ:MDLZ - Nasdaq - US6092071058 - Common Stock - Currency: USD

67.87  -0.26 (-0.38%)

After market: 67.87 0 (0%)

Fundamental Rating

5

Taking everything into account, MDLZ scores 5 out of 10 in our fundamental rating. MDLZ was compared to 89 industry peers in the Food Products industry. While MDLZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDLZ has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

MDLZ had positive earnings in the past year.
MDLZ had a positive operating cash flow in the past year.
Each year in the past 5 years MDLZ has been profitable.
Each year in the past 5 years MDLZ had a positive operating cash flow.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

1.2 Ratios

With a decent Return On Assets value of 6.73%, MDLZ is doing good in the industry, outperforming 73.03% of the companies in the same industry.
Looking at the Return On Equity, with a value of 17.12%, MDLZ belongs to the top of the industry, outperforming 86.52% of the companies in the same industry.
With an excellent Return On Invested Capital value of 10.27%, MDLZ belongs to the best of the industry, outperforming 83.15% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MDLZ is in line with the industry average of 9.00%.
The 3 year average ROIC (7.83%) for MDLZ is below the current ROIC(10.27%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.73%
ROE 17.12%
ROIC 10.27%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

The Profit Margin of MDLZ (12.65%) is better than 92.13% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has declined.
MDLZ has a Operating Margin of 18.37%. This is amongst the best in the industry. MDLZ outperforms 94.38% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a better Gross Margin (39.12%) than 87.64% of its industry peers.
MDLZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.37%
PM (TTM) 12.65%
GM 39.12%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
MDLZ has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
MDLZ has a better debt/assets ratio than last year.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

MDLZ has an Altman-Z score of 2.76. This is not the best score and indicates that MDLZ is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.76, MDLZ is doing good in the industry, outperforming 60.67% of the companies in the same industry.
MDLZ has a debt to FCF ratio of 5.04. This is a neutral value as MDLZ would need 5.04 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.04, MDLZ is in the better half of the industry, outperforming 70.79% of the companies in the same industry.
A Debt/Equity ratio of 0.58 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio (0.58) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.04
Altman-Z 2.76
ROIC/WACC1.34
WACC7.68%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.3 Liquidity

MDLZ has a Current Ratio of 0.68. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
MDLZ's Current ratio of 0.68 is on the low side compared to the rest of the industry. MDLZ is outperformed by 82.02% of its industry peers.
A Quick Ratio of 0.48 indicates that MDLZ may have some problems paying its short term obligations.
MDLZ's Quick ratio of 0.48 is on the low side compared to the rest of the industry. MDLZ is outperformed by 75.28% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.48
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

3

3. Growth

3.1 Past

MDLZ shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.86%.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
The Revenue has been growing slightly by 1.18% in the past year.
The Revenue has been growing slightly by 7.09% on average over the past years.
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%

3.2 Future

MDLZ is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.43% yearly.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 3.62% on average per year.
EPS Next Y-13.83%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
EPS Next 5Y4.43%
Revenue Next Year2.97%
Revenue Next 2Y3.63%
Revenue Next 3Y3.82%
Revenue Next 5Y3.62%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1 2 3 4 5

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.95, MDLZ is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
When comparing the Price/Earnings ratio of MDLZ to the average of the S&P500 Index (28.88), we can say MDLZ is valued slightly cheaper.
The Price/Forward Earnings ratio is 20.62, which indicates a rather expensive current valuation of MDLZ.
Based on the Price/Forward Earnings ratio, MDLZ is valued a bit cheaper than 65.17% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.20. MDLZ is around the same levels.
Industry RankSector Rank
PE 20.95
Fwd PE 20.62
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

MDLZ's Enterprise Value to EBITDA ratio is in line with the industry average.
MDLZ's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 24.96
EV/EBITDA 13.08
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

The excellent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)3.03
EPS Next 2Y-2.33%
EPS Next 3Y1.52%

6

5. Dividend

5.1 Amount

MDLZ has a Yearly Dividend Yield of 2.86%.
MDLZ's Dividend Yield is a higher than the industry average which is at 4.33.
MDLZ's Dividend Yield is comparable with the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 2.86%

5.2 History

On average, the dividend of MDLZ grows each year by 10.52%, which is quite nice.
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years10
Div Non Decr Years10
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

MDLZ pays out 50.94% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP50.94%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (5/1/2025, 4:40:43 PM)

After market: 67.87 0 (0%)

67.87

-0.26 (-0.38%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)04-29 2025-04-29/amc
Earnings (Next)07-28 2025-07-28/amc
Inst Owners85.54%
Inst Owner Change0.48%
Ins Owners0.14%
Ins Owner Change3.27%
Market Cap87.93B
Analysts76
Price Target71.37 (5.16%)
Short Float %1.73%
Short Ratio2.21
Dividend
Industry RankSector Rank
Dividend Yield 2.86%
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP50.94%
Div Incr Years10
Div Non Decr Years10
Ex-Date03-31 2025-03-31 (0.47)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.6%
Min EPS beat(2)-3.07%
Max EPS beat(2)14.26%
EPS beat(4)3
Avg EPS beat(4)5.8%
Min EPS beat(4)-3.07%
Max EPS beat(4)14.26%
EPS beat(8)7
Avg EPS beat(8)6.14%
EPS beat(12)11
Avg EPS beat(12)5.85%
EPS beat(16)12
Avg EPS beat(16)4.67%
Revenue beat(2)0
Avg Revenue beat(2)-1.66%
Min Revenue beat(2)-2.33%
Max Revenue beat(2)-0.99%
Revenue beat(4)0
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.6%
Revenue beat(8)3
Avg Revenue beat(8)-0.17%
Revenue beat(12)7
Avg Revenue beat(12)0.95%
Revenue beat(16)10
Avg Revenue beat(16)0.83%
PT rev (1m)5.4%
PT rev (3m)-10.58%
EPS NQ rev (1m)-1.22%
EPS NQ rev (3m)-21.99%
EPS NY rev (1m)0.1%
EPS NY rev (3m)-14.41%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-3.5%
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)-0.39%
Valuation
Industry RankSector Rank
PE 20.95
Fwd PE 20.62
P/S 2.41
P/FCF 24.96
P/OCF 17.91
P/B 3.26
P/tB N/A
EV/EBITDA 13.08
EPS(TTM)3.24
EY4.77%
EPS(NY)3.29
Fwd EY4.85%
FCF(TTM)2.72
FCFY4.01%
OCF(TTM)3.79
OCFY5.58%
SpS28.13
BVpS20.79
TBVpS-11.53
PEG (NY)N/A
PEG (5Y)3.03
Profitability
Industry RankSector Rank
ROA 6.73%
ROE 17.12%
ROCE 13.68%
ROIC 10.27%
ROICexc 10.56%
ROICexgc 86.77%
OM 18.37%
PM (TTM) 12.65%
GM 39.12%
FCFM 9.67%
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexcg growth 3Y30.99%
ROICexcg growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score8
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 5.04
Debt/EBITDA 1.97
Cap/Depr 106.53%
Cap/Sales 3.81%
Interest Coverage 12.09
Cash Conversion 61.39%
Profit Quality 76.4%
Current Ratio 0.68
Quick Ratio 0.48
Altman-Z 2.76
F-Score8
WACC7.68%
ROIC/WACC1.34
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-3.86%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-22.11%
EPS Next Y-13.83%
EPS Next 2Y-2.33%
EPS Next 3Y1.52%
EPS Next 5Y4.43%
Revenue 1Y (TTM)1.18%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%0.25%
Revenue Next Year2.97%
Revenue Next 2Y3.63%
Revenue Next 3Y3.82%
Revenue Next 5Y3.62%
EBIT growth 1Y17.29%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year7.92%
EBIT Next 3Y7.96%
EBIT Next 5Y8.23%
FCF growth 1Y-2.19%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y4.16%
OCF growth 3Y5.84%
OCF growth 5Y4.37%